盘龙药业：洛索洛芬钠凝胶贴膏获受理

Core Viewpoint - The company, Panlong Pharmaceutical, has received a notice from the National Medical Products Administration regarding the acceptance of its application for the marketing authorization of the generic drug, Loxoprofen Sodium Gel Patch, which is intended for the treatment of osteoarthritis, muscle pain, and swelling or pain from injuries [1] Group 1 - The Loxoprofen Sodium Gel Patch contains 100mg of Loxoprofen Sodium per patch, calculated as C15H17NaO3 [1] - Following the acceptance of the marketing authorization application, the product will undergo review and approval by the Drug Evaluation Center of the National Medical Products Administration, with completion time and approval results being uncertain [1]